Health Care

Electrical equipment maker Philips said a recent surge in orders for scanners and other medical equipment should enable group sales and margins to rebound over the next six months from a slump in the second quarter.

Uber Technologies Inc has quietly launched a service to give public health officials quick access to data on drivers and riders presumed to have come into contact with someone infected with COVID-19, company officials told Reuters.

Testees complain about waiting more than 10 days as coronavirus cases surge in U.S.

DoorDash announced a partnership Thursday with Walgreens Boots Alliance to deliver over-the-counter medication and other products from the drugstore chain.

Abbott Laboratories said demand is surging for its portfolio of tests for the coronavirus strain Covid-19 as the pandemic triggers unprecedented need for its diagnostic products around the world.

Moderna Inc’s (MRNA.O) shares rose 17% on Wednesday after a small-scale study showed its experimental COVID-19 vaccine produced high levels of virus-killing antibodies, bolstering hopes the shot could prove effective in later stages of testing.

The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc (REGN.O) for its potential COVID-19 antibody cocktail, the drugmaker said on Tuesday.

The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.

Gilead won the first Food and Drug Administration (FDA) emergency authorization for a COVID-19 treatment in May. Now, the biotech giant says, it will soon begin clinical trials for a different version of the same experimental drug, remdesivir, which might make it easier to administer outside of a hospital or ICU wing.

The coronavirus pandemic postponed the start of clinical trials for potentially life-changing, new medicines. It also could delay the time in which some of those drugs will reach the market as the U.S. Food and Drug Administration faces a potential surge in applications amid a pandemic. The full impact of the postponements for testing new drugs, treatments and vaccines for ailments besides Covid-19 may not be known for months.